Qube Research & Technologies (QRT)’s Editas Medicine EDIT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,045,255	Closed	-$7.76M	–	4026
2024 Q1	$7.76M	Buy	1,045,255 +661,810	+173%	+$5.5M	0.01%	985
2023 Q4	$3.88M	Buy	+383,445	New	+$3.37M	0.01%	1175
2023 Q3	–	Sell	-250,991	Closed	-$2.07M	–	4137
2023 Q2	$2.07M	Buy	250,991 +84,209	+50%	+$734K	0.01%	1044
2023 Q1	$1.21M	Buy	166,782 +133,705	+404%	+$1.19M	0.01%	1212
2022 Q4	$293K	Sell	33,077 -114,852	-78%	-$1.26M	﹤0.01%	1652
2022 Q3	$1.81M	Buy	+147,929	New	+$2.3M	0.01%	968
2022 Q2	–	Sell	-18,708	Closed	-$356K	–	2644
2022 Q1	$356K	Sell	18,708 -8,103	-30%	-$151K	﹤0.01%	1694
2021 Q4	$712K	Buy	26,811 +5,470	+26%	+$188K	0.01%	1384
2021 Q3	$877K	Buy	+21,341	New	+$1.17M	0.01%	955
2021 Q2	–	Sell	-15,486	Closed	-$650K	–	2389
2021 Q1	$650K	Buy	+15,486	New	+$882K	0.01%	1028
2020 Q4	–	Sell	-17,108	Closed	-$480K	–	1900
2020 Q3	$480K	Buy	+17,108	New	+$557K	0.01%	1050
2020 Q1	–	Sell	-35,987	Closed	-$1.07M	–	1252
2019 Q4	$1.07M	Buy	+35,987	New	+$899K	0.03%	582

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EDIT Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 1,045,255 shares — an estimated $7.76M sold.

Qube Research & Technologies (QRT) first reported a position in EDIT in Q4 2019 and held it in 12 quarters. The position peaked at $7.76M in Q1 2024. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

Qube Research & Technologies (QRT) reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 1,045,255 Editas Medicine shares in Q2 2024, an estimated $7.76M.
Qube Research & Technologies (QRT) first reported a position in Editas Medicine in Q4 2019 and held it in 12 quarters.
Qube Research & Technologies (QRT)'s Editas Medicine position peaked at $7.76M in Q1 2024.
235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.